{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:17:39Z","timestamp":1792034259207,"version":"4.4.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Atypical HUS (aHUS) is a disorder most commonly caused by inherited defects of the alternative pathway of complement, or the proteins that regulate this pathway, and life-threatening episodes of aHUS can be provoked by pregnancy. We retrospectively and prospectively investigated 27 maternal and fetal pregnancy outcomes in 14 women with aHUS from the Vienna Thrombotic Microangiopathy Cohort. Seven pregnancies (26%) were complicated by pregnancy-associated aHUS (p-aHUS), of which three appeared to be provoked by infection, bleeding, and curettage, and three individuals were considered to have preeclampsia\/HELLP syndrome before the definitive diagnosis of p-aHUS was made. Mutations in genes that encode the complement alternative pathway proteins or the molecules that regulate this pathway were detected in 71% of the women, with no relationship to pregnancy outcome. Twenty-one pregnancies (78%) resulted in a live birth, two preterm infants were stillborn, and four pregnancies resulted in early spontaneous abortions. Although short-term renal outcome was good in most women, long-term renal outcome was poor; among the 14 women, four had CKD stage 1\u20134, five had received a renal allograft, and three were dialysis-dependent at study end. We prospectively followed nine pregnancies of four women and treated six of these pregnancies with prophylactic plasma infusions (one pregnancy resulted in p-aHUS, one intrauterine fetal death occurred, and seven pregancies were uneventful). Our study emphasizes the frequency of successful pregnancies in women with aHUS. Close monitoring of such pregnancies for episodes of thrombotic microangiopathy is essential but, the best strategy to prevent these episodes remains unclear.<\/jats:p>","DOI":"10.1681\/asn.2016090995","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T04:05:16Z","timestamp":1604117116000},"page":"1020-1029","source":"Crossref","is-referenced-by-count":61,"title":["Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome"],"prefix":"10.1681","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-2245","authenticated-orcid":false,"given":"Martina","family":"Gaggl","sequence":"first","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Aigner","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-9852","authenticated-orcid":false,"given":"Dorottya","family":"Csuka","sequence":"additional","affiliation":[{"name":"Research Laboratory, 3rd Department of Medicine, Semmelweis University, Budapest, Hungary; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Szil\u00e1gyi","sequence":"additional","affiliation":[{"name":"Research Laboratory, 3rd Department of Medicine, Semmelweis University, Budapest, Hungary; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[{"name":"Research Laboratory, 3rd Department of Medicine, Semmelweis University, Budapest, Hungary; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2428-543X","authenticated-orcid":false,"given":"Renate","family":"Kain","sequence":"additional","affiliation":[{"name":"Clinical Institute of Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalja","family":"Haninger","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Knechtelsdorfer","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wilhelminenspital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raute","family":"Sunder-Plassmann","sequence":"additional","affiliation":[{"name":"Genetics Laboratory, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gere","family":"Sunder-Plassmann","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine III,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,12,27]]},"reference":[{"key":"B1-20231016","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B2-20231016","first-page":"423","article-title":"Irreversible post-partum renal failure. A new syndrome.","volume":"37","author":"Robson","year":"1968","journal-title":"Q J Med"},{"key":"B3-20231016","first-page":"662","article-title":"The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy.","volume":"91","author":"Dashe","year":"1998","journal-title":"Obstet Gynecol"},{"key":"B4-20231016","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2215\/CJN.13121211","article-title":"Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy.","volume":"7","author":"Fakhouri","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5-20231016","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.placenta.2010.03.010","article-title":"Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.","volume":"31","author":"Lynch","year":"2010","journal-title":"Placenta"},{"key":"B6-20231016","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: Conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) controversies conference.","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"B7-20231016","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0034-1375296","article-title":"Genetics of atypical hemolytic uremic syndrome (aHUS).","volume":"40","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"B8-20231016","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/asheducation.V2012.1.617.3798924","article-title":"Atypical hemolytic uremic syndrome: What is it, how is it diagnosed, and how is it treated?","volume":"2012","author":"Nester","year":"2012","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"B9-20231016","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0030-1262890","article-title":"Plasmatherapy in atypical hemolytic uremic syndrome.","volume":"36","author":"Loirat","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"B10-20231016","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"B11-20231016","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int"},{"key":"B12-20231016","article-title":"A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome [published online ahead of print September 11, 2017].","author":"Huerta","journal-title":"Kidney Int"},{"key":"B13-20231016","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1053\/j.ajkd.2015.08.023","article-title":"Perspectives on pregnancy in women with CKD: A semistructured interview study.","volume":"66","author":"Tong","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B14-20231016","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/ndt\/gfu378","article-title":"Perspectives on pregnancy in women with chronic kidney disease: Systematic review of qualitative studies.","volume":"30","author":"Tong","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B15-20231016","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/bmj.39406.652986.BE","article-title":"Chronic kidney disease in pregnancy.","volume":"336","author":"Williams","year":"2008","journal-title":"BMJ"},{"key":"B16-20231016","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2215\/CJN.09450912","article-title":"Obstetric nephrology: Pregnancy and the kidney--inextricably linked.","volume":"7","author":"August","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B17-20231016","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.AOG.0000258281.22296.de","article-title":"Imitators of severe preeclampsia.","volume":"109","author":"Sibai","year":"2007","journal-title":"Obstet Gynecol"},{"key":"B18-20231016","first-page":"129","article-title":"The renal lesion in preeclampsia.","volume":"5","author":"Spargo","year":"1976","journal-title":"Perspect Nephrol Hypertens"},{"key":"B19-20231016","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1681\/ASN.2007020255","article-title":"The glomerular injury of preeclampsia.","volume":"18","author":"Stillman","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B20-20231016","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0301-2115(02)00352-4","article-title":"Pathogenesis of acute renal failure associated with the HELLP syndrome: A case report and review of the literature.","volume":"108","author":"Abraham","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B21-20231016","first-page":"369","article-title":"A kidney biopsy is clearly mandatory to confirm the indication of plasma exchanges in adult haemolytic uraemic syndrome.","volume":"145","author":"Pourrat","year":"1994","journal-title":"Ann Med Interne (Paris)"},{"key":"B22-20231016","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.seminhematol.2013.06.004","article-title":"Hematologic complications of pregnancy.","volume":"50","author":"Townsley","year":"2013","journal-title":"Semin Hematol"},{"key":"B23-20231016","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.ogx.0000253301.55009.ac","article-title":"Clinical significance of proteinuria in pregnancy.","volume":"62","author":"Airoldi","year":"2007","journal-title":"Obstet Gynecol Surv"},{"key":"B24-20231016","first-page":"806","article-title":"Studies of complement levels in normal human pregnancy.","volume":"43","author":"Baines","year":"1974","journal-title":"Obstet Gynecol"},{"key":"B25-20231016","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/rheumatology\/kes225","article-title":"Primary anti-phospholipid syndrome: Any role for serum complement levels in predicting pregnancy complications?","volume":"51","author":"Reggia","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"B26-20231016","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Hemolytic uremic syndrome in pregnancy and postpartum.","volume":"12","author":"Bruel","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B28-20231016","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: Presentation, management, and subsequent pregnancy outcomes.","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"key":"B29-20231016","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria.","volume":"373","author":"Kelly","year":"2015","journal-title":"N Engl J Med"},{"key":"B30-20231016","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.imbio.2014.11.003","article-title":"Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn.","volume":"220","author":"Hallstensen","year":"2015","journal-title":"Immunobiology"},{"key":"B31-20231016","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/ndt\/gfw314","article-title":"Atypical haemolytic uraemic syndrome and pregnancy: Outcome with ongoing eculizumab.","volume":"31","author":"Servais","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B32-20231016","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/AOG.0b013e31828e2612","article-title":"Eculizumab for atypical hemolytic uremic syndrome in pregnancy.","volume":"122","author":"Ardissino","year":"2013","journal-title":"Obstet Gynecol"},{"key":"B34-20231016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ckj\/sfs185","article-title":"Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: Terminal complement activity assessment in clinical practice.","volume":"6","author":"Delmas","year":"2013","journal-title":"Clin Kidney J"},{"key":"B35-20231016","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-159-1-201307020-00023","article-title":"Successful treatment of the postpartum atypical hemolytic uremic syndrome with eculizumab.","volume":"159","author":"Zschiedrich","year":"2013","journal-title":"Ann Intern Med"},{"key":"B36-20231016","first-page":"1421","article-title":"Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.","volume":"93","author":"Ca\u00f1igral","year":"2014","journal-title":"Ann Hematol"},{"key":"B37-20231016","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/1752-1947-8-307","article-title":"Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: A case report.","volume":"8","author":"Kourouklaris","year":"2014","journal-title":"J Med Case Reports"},{"key":"B38-20231016","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s40620-015-0173-5","article-title":"Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: Insights for optimizing management.","volume":"28","author":"De Sousa Amorim","year":"2015","journal-title":"J Nephrol"},{"key":"B39-20231016","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bjh.14045","article-title":"How we manage thrombotic microangiopathies in pregnancy.","volume":"173","author":"Thomas","year":"2016","journal-title":"Br J Haematol"},{"key":"B40-20231016","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2004.10.018","article-title":"Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.","volume":"45","author":"Licht","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B41-20231016","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy.","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"B42-20231016","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults.","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B43-20231016","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1469-1809.2011.00671.x","article-title":"Age-related penetrance of hereditary atypical hemolytic uremic syndrome.","volume":"75","author":"Sullivan","year":"2011","journal-title":"Ann Hum Genet"},{"key":"B44-20231016","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am J Transplant"},{"key":"B45-20231016","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"key":"B46-20231016","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B47-20231016","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int"},{"key":"B48-20231016","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B49-20231016","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"B50-20231016","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.4049\/jimmunol.1100319","article-title":"A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.","volume":"188","author":"Sartz","year":"2012","journal-title":"J Immunol"},{"key":"B51-20231016","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"key":"B52-20231016","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53-20231016","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ajkd.2012.02.329","article-title":"Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency.","volume":"60","author":"Vernon","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B54-20231016","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.molimm.2006.08.004","article-title":"Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome.","volume":"44","author":"Monteferrante","year":"2007","journal-title":"Mol Immunol"},{"key":"B55-20231016","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","article-title":"Causes of alternative pathway dysregulation in dense deposit disease.","volume":"7","author":"Zhang","year":"2012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201803000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:31:13Z","timestamp":1786131073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201803000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,27]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2016090995","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,27]]}}}